WallStreetZenWallStreetZen

NASDAQ: GYRE
Gyre Therapeutics Inc Stock Ownership - Who owns Gyre Therapeutics?

Insider buying vs selling

Have Gyre Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Nassim UsmanDirector2024-03-1520,000$17.26
$345.20kSell
Nassim UsmanDirector2024-03-1520,000$6.93
$138.60kBuy

1 of 1

GYRE insiders have bought as... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GYRE insiders and whales buy or sell their stock.

GYRE Shareholders

What type of owners hold Gyre Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Gni Group Ltd2,775.51%70,272,408$1.18BInsider
Bvf Partners L P460.71%11,664,575$195.85MInsider
Iii Eugene A. Trainor309.14%7,827,024$131.42MInsider
Nea Partners 10 L P309.14%7,827,024$131.42MInsider
Investment 10 LLC243.76%6,171,669$103.62MInsider
C. Richard Kramlich180.61%4,572,845$76.78MInsider
Peter J. Barris180.53%4,570,845$76.74MInsider
M. James Barrett180.53%4,570,845$76.74MInsider
Scott D. Sandell180.49%4,569,845$76.73MInsider
Charles W. Newhall Iii180.40%4,567,512$76.69MInsider

1 of 3

GYRE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GYRE0.37%99.63%Net BuyingNet Buying
IRON44.60%55.40%Net SellingNet Selling
ADMA74.12%24.53%Net SellingNet Selling
KNSA48.47%9.84%Net SellingNet Selling
SLNO20.61%79.39%Net BuyingNet Selling

Gyre Therapeutics Stock Ownership FAQ

Who owns Gyre Therapeutics?

Gyre Therapeutics (NASDAQ: GYRE) is owned by 0.71% institutional shareholders, 189.84% Gyre Therapeutics insiders, and 0.00% retail investors. Gni Group Ltd is the largest individual Gyre Therapeutics shareholder, owning 70.27M shares representing 82.26% of the company. Gni Group Ltd's Gyre Therapeutics shares are currently valued at $1.23B.

If you're new to stock investing, here's how to buy Gyre Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.